Production (Stage)
CalciMedica, Inc.
CALC
$1.75
$0.052.94%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -18.41% | 24.21% | -42.08% | -3,141.54% | 103.14% |
Total Depreciation and Amortization | 7.14% | -6.67% | 7.14% | -6.67% | -21.05% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -6.17% | -253.77% | 137.89% | 55.47% | -3,833.62% |
Change in Net Operating Assets | 135.09% | 174.70% | 120.24% | -176.09% | -147.07% |
Cash from Operations | 1.89% | -6.54% | 31.29% | -44.05% | -30.54% |
Capital Expenditure | -350.00% | 66.67% | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 76.11% | -159.01% | 71.63% | 138.92% | -389.47% |
Cash from Investing | 75.94% | -159.07% | 71.51% | 138.92% | -389.47% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -89.06% | 55,662.50% | -- | -- | 10,844.25% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 20.40% | 55,662.50% | 328.57% | -100.04% | 10,781.71% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 479.70% | -129.71% | 341.08% | -238.69% | 120.04% |